Published in
Elsevier, The Lancet Oncology, 6(22), p. 801-812, 2021
DOI: 10.1016/s1470-2045(21)00128-5
Links
Tools
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Journal article published in 2021 by
Meletios A. Dimopoulos,
Evangelos Terpos,
Mario Boccadoro,
Sosana Delimpasi,
Meral Beksac,
Eirini Katodritou,
Philippe Moreau,
Luca Baldini,
Argiris Symeonidis,
Jelena Bila 
,
Albert Oriol,
Maria-Victoria Mateos,
Hermann Einsele,
Ioannis Orfanidis,
Tahamtan Ahmadi
and other authors.
,
Albert Oriol,
Maria-Victoria Mateos,
Hermann Einsele,
Ioannis Orfanidis,
Tahamtan Ahmadi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 